EL-102
CAS No. : 1233948-61-2
| Size | Price | Stock |
|---|---|---|
| 1mg | $110 | In-stock |
| 5mg | $280 | In-stock |
| 10mg | $448 | In-stock |
| 50mg | $940 | In-stock |
| 100mg | $1410 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-16187 |
| M.Wt: | 384.47 |
| Formula: | C19H16N2O3S2 |
| Purity: | >98 % |
| Solubility: | DMSO : ≥ 36 mg/mL (93.64 mM) |
EL-102 is a hypoxia-induced factor 1 (Hif1α) inhibitor. EL-102 induces apoptosis, inhibits tubulin polymerisation and shows activities against prostate cancer. EL-102 can be used for the research of cancer[1]. IC50 & Target: IC50: 24 nM (CWR22), 21.7 nM (22Rv1), 40.3 nM (DU145), 37.0 nM (PC-3), 14.4 nM (DLKP), 16.3 nM (DLKPA)[1] In Vitro: EL-102 (0-120 nM; 72 h) inhibits prostate cancer cells proliferation in vitro[1]. EL-102 (0-100 nM; 72 h) shows cytotoxicity to prostate cancer cell lines[1]. EL-102 (10-100 nM; 24-72 h) induces cellular apoptosis and affects cell cycle[1]. EL-102 (10-100 nM; 24-48 h) affects PARP cleavage in DU145 cells[1]. EL-102 (5 nM; 0-60 min) inhibits tubulin polymerisation activity[1]. EL-102 (0-100 nM; 1 hour) inhibits Hif1α protein expression[1]. In Vivo: EL-102 (12 and 15 mg/kg; p.o. 5-day on and 2-day off, from 13 to 37 days after tumour transplantation) potentiates effects of docetaxel in vivo[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- EL-102
- Cat. No.:
- HY-16187
- Quantity:
Your information is safe with us.